"Cervical Cancer and Science Popularization" is a great example of a paper on cancer. The increasing incidences of cervical cancer among women have led to increased research on remedial measures. This is happening at a time when the rate of HIV infection particularly in developing countries has a high rate of prevalence. The challenge that has arisen from this situation is how to reconcile the cancer vaccines with the immunity-related problem of HIV infected women. According to an article appearing in the New York Times, Cancer Vaccine Proves Effective in H. I.V. Patients. April 21, 2014, Donald G. Mcneil Jr.
explains how new research shows that new cancer vaccines can effectively be used safely by HIV infected women. This is a medical breakthrough that is significant as far as healthcare quality and scientific research milestones are concerned. Vaccines against cervical cancer show a high probability of working well even in sexually active women who are H. I.V positive, the new research study has established. It also established that women who already have one or two strains of the cervical cancer-causing virus can be protected against others. This research is at the experimental life cycle of biomedical discovery and attracts significant interest across the society (Rolland 225).
This article shows the ongoing research on cancer vaccine and how it can be integrated into the suppressed immune system of women infected with HIV. A scientific journal on Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women by Erna Milunka Kojic et al. is a close research paper on the same subject. The findings of this research paper evoke the need for increased funding towards cancer and HIV anti-immune depressant vaccines. It can be noted that Dr. Erna Milunka Kojic has been mentioned in the article on the New York Times which is a critical indicator of the level of seriousness placed on this biomedical issue.
Further trials of vaccines and continued experiments of the findings on the journal require funding from biomedical investigations funding agencies. The presentation of the issue in the article in the New York Times constitutes a significant application of rhetoric tools to attract the attention of the funding agencies and the public in general. Stanford School of Medicine through the Mary Kay Foundation Cancer Research Grant Program is one of the founders of cancer-related research but is very stringent in minimum requirements for potential beneficiaries. Taking some direct quotes from the article appearing in the New York Times for instance, “ We saw it differently, ” Dr.
Kojic said. Women with H. I.V. , she said, “ bear the biggest burden, so if it worked, they would benefit the most from it. ” . This excerpt shows the application of ethos which is appealing to the funding agency and the public as the bulk of the world population is women and this cancer has affected many families. Such a medical appeal with more reliable and valid research findings will popularize the scientific idea and cancer awareness versus HIV suppression in the immunity of infected women (Jakowlew 45).
It can be observed that the mode of presenting the research finding and language skills is significant in popularizing and security financial grants to undertake biomedical research and subsequent implementation of the findings.
Donald G. Mcneil Jr. Cancer Vaccine Proves Effective in H.I.V. Patients .April 21, 2014
Retrieved on 21st April 22, 2014 from:
Erna Milunka Kojic,Minhee Kang, Michelle S. Cespedes,Triin Umbleja,Catherine Godfrey,Reena T. Allen,Cynthia Firnhaber,Beatriz Grinsztejn,Joel M. Palefsky,Jennifer Y. Webster-Cyriaque,Alfred Saah, Judith A. Aberg, and Susan Cu-Uvin. Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women. Oxford Journal. Oxford University Press. January 17, 2014
Retrieved on 21st April 22, 2014 from:
Mary Kay Foundation Cancer Research Grant Program (http://med.stanford.edu/rmg/funding/marykay.html)
Rolland, George Z. New Research on Cervical Cancer. New York: Nova Science Publishers, 2007. Print.
Jakowlew, Sonia B. Transforming Growth Factor-[beta] in Cancer Therapy. Totowa, N.J: Humana Press, 2008. Print.